Cellectis Adr (CLLS)

Sep 24, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A.CLLS - PR Newswire

Sep 24, 2026

Sep 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS - FinancialContent

Sep 22, 2026

Sep 18, 2026

European ADRs Slip In US Trading As Biotech Splits - Finimize

Sep 18, 2026

Sep 17, 2026

European ADRs Rose Late Thursday Morning, Led By Biotech - Finimize

Sep 17, 2026

Sep 16, 2026

European ADRs Inched Up As Telecom And Biotech Led - Finimize

Sep 16, 2026

Sep 15, 2026

This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Sep 15, 2026

Sep 15, 2026

CLLS Stock Slides Toward 14-Month Low: Citizens Downgrades Cellectis After Cancer Pipeline Pivot - Stocktwits

Sep 15, 2026

Sep 14, 2026

Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Sess - Benzinga

Sep 14, 2026

Sep 11, 2026

Cellectis organise une conférence téléphonique et un webcast le 14 septembre pour présenter un point d’activité - GlobeNewswire Inc.

Sep 11, 2026

Sep 10, 2026

European ADRs Slipped In US Trading Late Thursday Morning - Finimize

Sep 10, 2026

Sep 05, 2026

Cellectis (NASDAQ:CLLS): Is Its Latest Rally More Than Technical? - Kalkine Media

Sep 05, 2026

Aug 25, 2026

European ADRs Edged Higher As Biotech Led The Pack - Finimize

Aug 25, 2026

Aug 06, 2026

Cellectis earnings beat by $0.04, revenue fell short of estimates - Investing.com

Aug 06, 2026

Aug 06, 2026

Cellectis Reports Financial Results for the Second Quarter 2026 - Barchart.com

Aug 06, 2026

Jul 25, 2026

Cellectis S.A. Sponsored ADR Revenue Breakdown – LS:A14QZE - TradingView

Jul 25, 2026

Jul 22, 2026

European ADRs Traded Higher In US Morning Session - Finimize

Jul 22, 2026

Jul 16, 2026

ETFs Investing in Cellectis S.A. Sponsored ADR Stocks - TradingView

Jul 16, 2026

Jul 07, 2026

Multiple Myeloma Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics, Poseida Therapeutics - Barchart.com

Jul 07, 2026

Jul 02, 2026

European ADRs Jumped As Biotech Led The Pack - Finimize

Jul 02, 2026

Jul 01, 2026

Cellectis S.A. Sponsored ADR Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 29, 2026

European ADRs Rose As Biopharma Names Led The Pack - Finimize

Jun 29, 2026

Jun 27, 2026

A14QZE Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Jun 26, 2026

Cellectis S.A. Sponsored ADR Actuals & Estimates (NASDAQ:CLLS) - TradingView

Jun 26, 2026

Jun 26, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 26, 2026

Jun 18, 2026

European ADRs Slip, Even As Biotech Names Edge Higher - Finimize

Jun 18, 2026

Jun 11, 2026

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress - Barchart.com

Jun 11, 2026

Jun 10, 2026

Cellectis stock rises on FDA therapy designation - Investing.com

Jun 10, 2026

Jun 10, 2026

Cellectis stock rises on FDA therapy designation By Investing.com - Investing.com India

Jun 10, 2026

Jun 02, 2026

CLLS Stock Chart | CELLECTISADR (NASDAQ:CLLS) - ChartMill

Jun 02, 2026

May 28, 2026

Barclays initiates Cellectis stock with overweight, $9 target - Investing.com

May 28, 2026

May 27, 2026

CLLS - Finviz

May 27, 2026

May 22, 2026

Cellectis’s SWOT analysis: biotech stock shows promise in CAR-T therapy - Investing.com

May 22, 2026

May 19, 2026

CLLS Stock Price, Quote & Chart | CELLECTISADR (NASDAQ:CLLS) - ChartMill

May 19, 2026

May 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress - ChartMill

May 12, 2026

May 11, 2026

Cellectis Reports Financial Results for the First Quarter 2026 - ChartMill

May 11, 2026

Apr 28, 2026

TL ResistanceStock ScreenerCharts - Finviz

Apr 28, 2026

Apr 27, 2026

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting - ChartMill

Apr 27, 2026

Apr 21, 2026

European ADRs Open Lower As Telecoms And Biotech Split - Finimize

Apr 21, 2026

Apr 14, 2026

Cellectis stock rating held at outperform on allogeneic platform - Investing.com

Apr 14, 2026

Apr 13, 2026

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform - ChartMill

Apr 13, 2026

Apr 10, 2026

European ADRs Headed For A Strong Week In US Trading - Finimize

Apr 10, 2026

Apr 07, 2026

Monthly information on share capital and company voting rights - ChartMill

Apr 07, 2026

Mar 23, 2026

Citizens reiterates Cellectis stock rating on CAR-T progress By Investing.com - Investing.com South Africa

Mar 23, 2026